Early CPAP nonadherence does not predict long-term treatment failure

The Hidden Struggle with CPAP Adherence: Why Early “Failure” Isn’t the End of the Road

For many people diagnosed with obstructive sleep apnea (OSA), the journey to better sleep begins with a CPAP (continuous positive airway pressure) machine. However, the road to consistent use is often bumpy. While clinicians understand that adapting to a mask and pressurized air takes time, insurance policies often tell a different story.

Current industry standards—most notably Medicare policy—rely on a strict window of early use to determine if a patient “succeeds” with the therapy. If a patient doesn’t hit specific usage targets within the first 90 days, they risk losing their insurance coverage entirely.

Challenging the “90-Day Rule”: What the Data Shows

The assumption that poor early use predicts long-term failure is now being challenged by significant new evidence. Research presented at the ATS 2026 International Conference suggests that the current thresholds used by insurers may be prematurely cutting off patients who would eventually thrive on the therapy.

In a massive study involving more than 132,000 patients treated for OSA within Kaiser Permanente Southern California, researchers found a striking gap between insurance criteria and actual patient behavior. According to the data, 51 percent of patients failed to meet the 90-day Medicare criteria for continued use.

The Medicare policy in question requires patients to use their CPAP for at least four hours each night on 70 percent of nights during a 30-day window within those first 90 days. But is this “all-or-nothing” approach clinically sound?

“Our findings suggest clinicians and policymakers should not rely solely on Medicare-defined adherence, given its reliance on early CPAP use and an arbitrary four-hour threshold, when making long-term treatment decisions. Extending support and coverage beyond the first 90 days could help more patients achieve meaningful benefit.” — Dennis Hwang, MD, sleep and pulmonary physician at Kaiser Permanente Southern California

Why “Nonadherence” Isn’t Always Treatment Failure

The most surprising finding from the Kaiser Permanente study is that many patients who “failed” the initial insurance test didn’t actually give up. More than one-third of the patients who did not meet the early Medicare use criteria were still utilizing their CPAP machines one year later.

the definition of “success” itself is under scrutiny. While the insurance threshold is set at four hours, Dr. Hwang noted that even patients who didn’t hit that mark were often using their devices for at least two hours a night—a duration known to improve sleep apnea symptoms.

Future Trends: Moving Toward Outcome-Based Coverage

As this data gains traction, the medical community is pushing for a shift in how sleep apnea therapy is managed and funded. We are likely moving toward a more nuanced, patient-centric model of care.

1. From Arbitrary Thresholds to Clinical Outcomes

The future of CPAP coverage will likely move away from “stopwatch” metrics (how many hours a night) and toward outcome-based metrics (how much the patient’s health is actually improving). If a patient’s symptoms are resolving, the exact number of hours spent wearing the mask may become secondary.

2. Extended Adaptation Windows

Recognizing that some patients take longer to adapt to the equipment, there is a growing call to extend support and coverage beyond the first 90 days. This would prevent patients from losing access to life-saving treatment during the critical learning curve of the first few months.

3. Personalized Adherence Profiles

Future clinical practice may involve identifying “leisurely responders”—patients who struggle initially but eventually become long-term users. By understanding these profiles, doctors can provide targeted support to those most likely to benefit in the long run, rather than labeling them as “non-compliant.”

Frequently Asked Questions